2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Nucleoredoxin interaction with flightless-I/actin complex is differentially altered in alcoholic liver disease.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Alcoholic liver disease (ALD) may be attributed to multiple hits driving several alterations. The aim of this work was to determine whether nucleoredoxin (NXN) interacts with flightless-I (FLII)/actin complex and how this ternary complex is altered during ALD progression induced by different ALD models. ALD was recapitulated in C57BL/6J female mice by the well-known ALD Lieber-DeCarli model, and by an in vitro human co-culture system overexpressing NXN. The effects of ethanol and low doses of lipopolysaccharides (LPS) and diethylnitrosamine (DEN) were also evaluated in vivo as a first approach of an ALD multi-hit protocol. We demonstrated that NXN interacts with FLII/actin complex. This complex was differentially altered in ALD in vivo and in vitro, and NXN overexpression partially reverted this alteration. We also showed that ethanol, LPS and DEN synergistically induced liver structural disarrangement, steatosis and inflammatory infiltration accompanied by increased levels of proliferation (Ki67), ethanol metabolism (CYP2E1), hepatocarcinogenesis (GSTP1) and LPS-inducible (MYD88 and TLR4) markers. In summary, we provide evidence showing that NXN/FLII/actin complex is involved in ALD progression and that NXN might be involved in the regulation of FLII/actin-dependent cellular functions. Moreover, we present a promising first approach of a multi-hit protocol to better recapitulate ALD pathogenesis.

          Related collections

          Author and article information

          Journal
          Basic Clin Pharmacol Toxicol
          Basic & clinical pharmacology & toxicology
          Wiley
          1742-7843
          1742-7835
          Nov 2020
          : 127
          : 5
          Affiliations
          [1 ] Laboratory of Liver Diseases, National Institute of Genomic Medicine, CDMX, Mexico.
          [2 ] Departament of Cell Biology, Center for Research and Advanced Studies of the National Polytechnic Institute, CDMX, Mexico.
          [3 ] Laboratory of Cardiovascular Diseases, National Institute of Genomic Medicine, CDMX, Mexico.
          [4 ] Proteomics Unit, National Institute of Genomic Medicine, CDMX, Mexico.
          [5 ] Lipid Research Laboratory, VA Medical Center, Washington, DC, USA.
          [6 ] Department of Biochemistry and Molecular Medicine, The George Washington University Medical Center, Washington, DC, USA.
          [7 ] Research Laboratory in Immunology and Proteomics, Children's Hospital of Mexico "Federico Gómez", CDMX, Mexico.
          [8 ] Research Department in Community Health, Children's Hospital of Mexico "Federico Gómez", CDMX, Mexico.
          [9 ] Directorate of Cátedras, National Council of Science and Technology, CDMX, Mexico.
          Article
          10.1111/bcpt.13451
          32524749
          98005fa7-da96-4da8-bd9a-272e4c3d6e21
          History

          diethylnitrosamine,lipopolysaccharides,oxidative stress,alcohol consumption,ethanol

          Comments

          Comment on this article